NasdaqGM:LGNDPharmaceuticals
Ligand Pharmaceuticals (LGND): Evaluating Valuation After FDA Green Light for Lasix ONYU’s At-Home Heart Failure Solution
Ligand Pharmaceuticals (LGND) shares drew attention after the company and SQ Innovation Inc. received FDA approval for Lasix ONYU, a drug-device product for adults with chronic heart failure. The product enables patients to manage edema at home.
See our latest analysis for Ligand Pharmaceuticals.
Momentum has accelerated for Ligand Pharmaceuticals, with the FDA clearance of Lasix ONYU appearing to fuel market optimism. After a stellar 46% share price return over the past three months and a...